LX-6171 is an orally active SLC6A7 inhibitor. LX-6171 can be used to study diseases characterized by cognitive impairment, such as Alzheimers disease, schizophrenia or vascular dementia[1].
Molecular Weight:
377.87
CAS Number:
[914808-66-5]
Formula:
C22H20ClN3O
Target:
Amino acid Transporter
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
